Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08HYX
|
|||
| Former ID |
DNC011619
|
|||
| Drug Name |
4-Hex-3-ynyl-1H-imidazole
|
|||
| Synonyms |
CHEMBL14721; 4-Hex-3-ynyl-1H-imidazole; SCHEMBL7627737; 4-(3-Hexynyl)-1H-imidazole; BDBM50070219
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H12N2
|
|||
| Canonical SMILES |
CCC#CCCC1=CN=CN1
|
|||
| InChI |
1S/C9H12N2/c1-2-3-4-5-6-9-7-10-8-11-9/h7-8H,2,5-6H2,1H3,(H,10,11)
|
|||
| InChIKey |
KXZPBLYVPNSMHH-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine H3 receptor (H3R) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Histamine receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | Monoamine Transport | |||
| GPCRs, Class A Rhodopsin-like | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | New acetylene based histamine H3 receptor antagonists derived from the marine natural product verongamine. Bioorg Med Chem Lett. 1998 May 19;8(10):1133-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.